Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zefeng Xu

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 26, 2016
[Long-term outcomes of homoharringtonine, cytarabine, daunorubicin or idarubicin (HAD/HAI) as induction chemotherapy in de novo acute myeloid leukemia]Tiejun Qin, Zefeng Xu, Yue Zhang, et al.
FEBS Letters|February 8, 2017
MLF1IP promotes normal erythroid proliferation and is involved in the pathogenesis of polycythemia veraGege Feng, Tianjiao Zhang, Jinqin Liu, et al.
Blood Science (Baltimore, Md.)|November 9, 2023
Micheliolide exerts effects in myeloproliferative neoplasms through inhibiting STAT3/5 phosphorylation via covalent binding to STAT3/5 proteinsHuijun Huang, Jinqin Liu, Lin Yang, et al.
Hematological Oncology|June 18, 2026
Impact of U2AF1 Pathogenic Variants on Prognosis of Myelodysplastic Neoplasms With RUNX1 MutationLinlin Liu, Bing Li, Tiejun Qin, et al.
Pathology, Research and Practice|April 1, 2025
GATA1 insufficiencies in dysmegakaryopoiesis of myelodysplastic syndromes/neoplasmsFuhui Li, Yudi Zhang, Chengwen Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 16, 2016
[The assessment of symptomatic burden among Ph/BCR- ABL negative myeloproliferative neoplasm patients]Junqing Xu, Zefeng Xu, Jingya Wang, et al.
Experimental Hematology & Oncology|March 20, 2021
VEXAS syndrome in myelodysplastic syndrome with autoimmune disorderHuijun Huang, Wenjun Zhang, Wenyu Cai, et al.
Leukemia Research|September 4, 2014
Prognostic impact of splenomegaly on survival of Chinese with primary myelofibrosisJingya Wang, Junqing Xu, Robert Peter Gale, et al.
British Journal of Haematology|March 6, 2019
Prognostic impact of red blood cell distribution width in myelodysplastic syndromesZhongxun Shi, Bing Li, Huijun Huang, et al.
Leukemia|September 9, 2021
RBC distribution width predicts thrombosis risk in polycythemia veraDan Liu, Bing Li, Zefeng Xu, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 26, 2016
[Long-term outcomes of homoharringtonine, cytarabine, daunorubicin or idarubicin (HAD/HAI) as induction chemotherapy in de novo acute myeloid leukemia]Tiejun Qin, Zefeng Xu, Yue Zhang, et al.
FEBS Letters|February 8, 2017
MLF1IP promotes normal erythroid proliferation and is involved in the pathogenesis of polycythemia veraGege Feng, Tianjiao Zhang, Jinqin Liu, et al.
Blood Science (Baltimore, Md.)|November 9, 2023
Micheliolide exerts effects in myeloproliferative neoplasms through inhibiting STAT3/5 phosphorylation via covalent binding to STAT3/5 proteinsHuijun Huang, Jinqin Liu, Lin Yang, et al.
Hematological Oncology|June 18, 2026
Impact of U2AF1 Pathogenic Variants on Prognosis of Myelodysplastic Neoplasms With RUNX1 MutationLinlin Liu, Bing Li, Tiejun Qin, et al.
Pathology, Research and Practice|April 1, 2025
GATA1 insufficiencies in dysmegakaryopoiesis of myelodysplastic syndromes/neoplasmsFuhui Li, Yudi Zhang, Chengwen Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 16, 2016
[The assessment of symptomatic burden among Ph/BCR- ABL negative myeloproliferative neoplasm patients]Junqing Xu, Zefeng Xu, Jingya Wang, et al.
Experimental Hematology & Oncology|March 20, 2021
VEXAS syndrome in myelodysplastic syndrome with autoimmune disorderHuijun Huang, Wenjun Zhang, Wenyu Cai, et al.
Leukemia Research|September 4, 2014
Prognostic impact of splenomegaly on survival of Chinese with primary myelofibrosisJingya Wang, Junqing Xu, Robert Peter Gale, et al.
British Journal of Haematology|March 6, 2019
Prognostic impact of red blood cell distribution width in myelodysplastic syndromesZhongxun Shi, Bing Li, Huijun Huang, et al.
Leukemia|September 9, 2021
RBC distribution width predicts thrombosis risk in polycythemia veraDan Liu, Bing Li, Zefeng Xu, et al.
Pageof 13